Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Kali Inc Announces Cannabis Pharmaceutical and Concentrates Business Plan Presentation Schedule for Tomorrow November 20th 2018

Kali
Posted on: 20 Nov 18

SARASOTA, Florida, November 19, 2018 /PRNewswire/ --

Kali, Inc. (USOTC: KALY) today announced an online presentation scheduled for tomorrow, November 20th 2018, to present the company's new cannabis pharmaceutical and concentrates business plan following the acquisition of NCM Biotech announced last week. NCM Biotech is the developer and owner of a patented cannabis extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."  The cannabis pharmaceuticals market is forecasted to reach $50 billion in sales by 2029 . The cannabis concentrates for wellness, edibles and recreational markets is forecasted to reach $8.5 billion in annual sales by 2022 . NCM Biotech's current research and ongoing pharmaceutical developments come with the acquisition and the presentation will feature a timely and specific university research initiative expected to reach an important benchmark very soon. The presentation will include more details on the recent acquisition of NCM Biotech to include emphasizing that the company does not intend to execute a reverse or forward stock split in conjunction with the recently executed acquisition. The shareholder presentation will be published from a new company website.  

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT:
Kali, Inc.
+1-941-444-6994
management@wavemarineservices.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 20/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.